-+ 0.00%
-+ 0.00%
-+ 0.00%

FREENOME EXPANDS PERSONALIZED CANCER DETECTION PORTFOLIO, LAUNCHING SIMPLESCREEN™ LUNG TEST WITH FDA-APPROVED SIMPLESCREEN CRC OPTION

Reuters·10/20/2026 12:30:26

Please log in to view news